NEW YORK (GenomeWeb News) – Complete Genomics said today that it has raised $45 million from new and previous investors, and it will use the funds to build up its Silicon Valley genome sequencing facility.

The Series D financing included two new investors, Essex Woodlands Health Ventures and OrbiMed Advisors, as well as investments from Enterprise Partners Venture Capital, OVP Venture Partners, Prospect Venture Partners, and Highland Capital Management.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: multiplex genotyping of germline and somatic short tandem repeats, graph-based regularization, and more.

A lack of funding may lead more than two dozen research facilities in Australia to shut down in three months.

Researchers report that paternally inherited genes are more likely to be expressed in mice.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.